Literature DB >> 19822209

Syndromic features and mild cognitive impairment in mice with genetic reduction on p300 activity: Differential contribution of p300 and CBP to Rubinstein-Taybi syndrome etiology.

Jose Viosca1, Jose P Lopez-Atalaya, Roman Olivares, Richard Eckner, Angel Barco.   

Abstract

Rubinstein-Taybi syndrome (RSTS) is a complex autosomal-dominant disease characterized by mental and growth retardation and skeletal abnormalities. A majority of the individuals diagnosed with RSTS carry heterozygous mutation in the gene CREBBP, but a small percentage of cases are caused by mutations in EP300. To investigate the contribution of p300 to RSTS pathoetiology, we carried out a comprehensive and multidisciplinary characterization of p300(+/-) mice. These mice exhibited facial abnormalities and impaired growth, two traits associated to RSTS in humans. We also observed abnormal gait, reduced swimming speed, enhanced anxiety in the elevated plus maze, and mild cognitive impairment during the transfer task in the water maze. These analyses demonstrate that p300(+/-) mice exhibit phenotypes that are reminiscent of neurological traits observed in RSTS patients, but their comparison with previous studies on CBP deficient strains also indicates that, in agreement with the most recent findings in human patients, the activity of p300 in cognition is likely less relevant or more susceptible to compensation than the activity of CBP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19822209     DOI: 10.1016/j.nbd.2009.10.001

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  25 in total

Review 1.  The role of histone acetylation in memory formation and cognitive impairments.

Authors:  Lucia Peixoto; Ted Abel
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

Review 2.  Acetyltransferases (HATs) as targets for neurological therapeutics.

Authors:  Anne Schneider; Snehajyoti Chatterjee; Olivier Bousiges; B Ruthrotha Selvi; Amrutha Swaminathan; Raphaelle Cassel; Frédéric Blanc; Tapas K Kundu; Anne-Laurence Boutillier
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

3.  Subregion-specific p300 conditional knock-out mice exhibit long-term memory impairments.

Authors:  Ana M M Oliveira; Marcel A Estévez; Joshua D Hawk; Shannon Grimes; Paul K Brindle; Ted Abel
Journal:  Learn Mem       Date:  2011-02-23       Impact factor: 2.460

Review 4.  Protein lysine acetylation by p300/CBP.

Authors:  Beverley M Dancy; Philip A Cole
Journal:  Chem Rev       Date:  2015-01-16       Impact factor: 60.622

Review 5.  Genetic syndromes caused by mutations in epigenetic genes.

Authors:  María Berdasco; Manel Esteller
Journal:  Hum Genet       Date:  2013-01-31       Impact factor: 4.132

6.  Inhibition of p300 histone acetyltransferase activity in palate mesenchyme cells attenuates Wnt signaling via aberrant E-cadherin expression.

Authors:  Dennis R Warner; Scott C Smith; Irina A Smolenkova; M Michele Pisano; Robert M Greene
Journal:  Exp Cell Res       Date:  2016-02-24       Impact factor: 3.905

7.  Language and Cognitive Impairment Associated with a Novel p.Cys63Arg Change in the MED13L Transcriptional Regulator.

Authors:  Salud Jiménez-Romero; Pilar Carrasco-Salas; Antonio Benítez-Burraco
Journal:  Mol Syndromol       Date:  2018-01-11

8.  CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement.

Authors:  Jose P Lopez-Atalaya; Alessandro Ciccarelli; Jose Viosca; Luis M Valor; Maria Jimenez-Minchan; Santiago Canals; Maurizio Giustetto; Angel Barco
Journal:  EMBO J       Date:  2011-08-16       Impact factor: 11.598

Review 9.  Bromodomains as therapeutic targets.

Authors:  Susanne Muller; Panagis Filippakopoulos; Stefan Knapp
Journal:  Expert Rev Mol Med       Date:  2011-09-13       Impact factor: 5.600

10.  Genetic mapping and exome sequencing identify variants associated with five novel diseases.

Authors:  Erik G Puffenberger; Robert N Jinks; Carrie Sougnez; Kristian Cibulskis; Rebecca A Willert; Nathan P Achilly; Ryan P Cassidy; Christopher J Fiorentini; Kory F Heiken; Johnny J Lawrence; Molly H Mahoney; Christopher J Miller; Devika T Nair; Kristin A Politi; Kimberly N Worcester; Roni A Setton; Rosa Dipiazza; Eric A Sherman; James T Eastman; Christopher Francklyn; Susan Robey-Bond; Nicholas L Rider; Stacey Gabriel; D Holmes Morton; Kevin A Strauss
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.